Microbiologically confirmed infections and antibiotic-resistance in a national surveillance study of hospitalised patients who died with COVID-19, Italy 2020–2021
Authors:
Open Access
- 21 May 2022
- journal article
- research article
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 11 (1) , 1-9
Abstract
Background: Patients hospitalised for COVID-19 may present with or acquire bacterial or fungal infections that can affect the course of the disease. The aim of this study was to describe the microbiological characteristics of laboratory-confirmed infections in hospitalised patients with severe COVID-19.Methods: We reviewed the hospital charts of a sample of patients deceased with COVID-19 from the Italian National COVID-19 Surveillance, who had laboratory-confirmed bacterial or fungal bloodstream infections (BSI) or lower respiratory tract infections (LRTI), evaluating the pathogens responsible for the infections and their antimicrobial susceptibility.Results: Among 157 patients with infections hospitalised from February 2020 to April 2021, 28 (17.8%) had co-infections (≤ 48 h from admission) and 138 (87.9%) had secondary infections (> 48 h). Most infections were bacterial; LRTI were more frequent than BSI. The most common co-infection was pneumococcal LRTI. In secondary infections, Enterococci were the most frequently recovered pathogens in BSI (21.7% of patients), followed byEnterobacterales, mainlyK. pneumoniae, while LRTI were mostly associated with Gram-negative bacteria, firstlyEnterobacterales(27.4% of patients,K. pneumoniae15.3%), followed byA. baumannii(19.1%). Fungal infections, both BSI and LRTI, were mostly due toC. albicans. Antibiotic resistance rates were extremely high in Gram-negative bacteria, with almost allA. baumanniiisolates resistant to carbapenems (95.5%), andK. pneumoniaeandP. aeruginosashowing carbapenem resistance rates of 59.5% and 34.6%, respectively.Conclusions: In hospitalised patients with severe COVID-19, secondary infections are considerably more common than co-infections, and are mostly due to Gram-negative bacterial pathogens showing a very high rate of antibiotic resistance.Keywords
This publication has 26 references indexed in Scilit:
- Co-infections in people with COVID-19: a systematic review and meta-analysisJournal of Infection, 2020
- Community-acquired Coinfection in Coronavirus Disease 2019: A Retrospective Observational ExperienceClinical Infectious Diseases, 2020
- Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in ItalyThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2020
- Antimicrobial use, drug-resistant infections and COVID-19Nature Reviews Microbiology, 2020
- Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter studyJournal of Infection, 2019
- Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysisThe Lancet Infectious Diseases, 2019
- The frequency of influenza and bacterial coinfection: a systematic review and meta‐analysisInfluenza and Other Respiratory Viruses, 2016
- Systematic Review and Meta-Analysis of a Urine-Based Pneumococcal Antigen Test for Diagnosis of Community-Acquired Pneumonia Caused by Streptococcus pneumoniaeJournal of Clinical Microbiology, 2013
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination TherapyClinical Infectious Diseases, 2012
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care settingAmerican Journal of Infection Control, 2008